Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1110 of 1,261
  1. US 7060712

    Crystalline form of aryl aniline β2 adrenergic receptor agonist

    Theravance, Inc. · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  2. US 7060686

    Anti-inflammatory compounds derived from Pseudopterogorgia elisabethae

    The Regents of the University of California · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  3. US 7060688

    Products and methods for controlling the suppression of the neoplastic phenotype

    The Regents of the University of California · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  4. US 7060703

    Indolinone derivatives

    Theravance, Inc. · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  5. US 7060837

    Method for the purification of lansoprazole

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  6. US 7061237

    Remote NMR/MRI detection of laser polarized gases

    The Regents of the University of California · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  7. US 7056501

    Recombinant neospora antigens and their uses

    The Regents of the University of California · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  8. US 7056513

    Telomerase

    The Regents of the University of Colorado · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  9. US 7056503

    Enclosures housing cell-coated supports for treating tumors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  10. US 7056506

    Methods for detecting and inhibiting angiogenesis

    The Regents of the University of California · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  11. US 7057076

    Bicyclic and tricyclic cannabinoids

    UNIVERSITY OF CONNECTICUT · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  12. US 7056509

    Antibody methods for selectively inhibiting VEGF

    The Board of Regents of the University of Texas System · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  13. US 7056734

    Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof

    The United States of America, as represented by the Department of Health and Human Services, N.I.H. · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  14. US 7056500

    Polymer conjugates of opioid antagonists

    Nektar Therapeutics AL, Corporation · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  15. US 7056532

    Compositions for delivery of biological agents and methods for the preparation thereof

    Univ. Nebraska Bd. of Regents · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  16. US 7056944

    Pyrazole compositions useful as inhibitors of erk

    Vertex Pharmaceuticals Incorporated · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  17. US 7056954

    Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor

    Ligand Pharmaceuticals Incorporated · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  18. US 7056901

    Microgel particles for the delivery of bioactive materials

    The Regents of the University of California · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  19. US 7056908

    Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  20. US 7056927

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  21. US 7056942

    Carvedilol

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  22. US 7057029

    Human ion-exchanger proteins

    Lexicon Genetics, Inc. · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  23. US 7056945

    Selective inhibition of neuronal nitric oxide synthase

    The Regents of the University of California · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  24. US 7056514

    Partial peptide mimetics and methods

    Regents of the University of Minnesota · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.